EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

Published 2011 View Full Article

Authors

Keywords

Journal

LANCET ONCOLOGY

Volume 13, Issue 1, Pages 33-42

Publisher

Elsevier BV

Online

2011-11-05

DOI

10.1016/s1470-2045(11)70318-7

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

LANCET ONCOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Create your own webinar